Walter Stummer

13PUBLICATIONS

29CO-AUTHORS

Cellular nervous systemExercise physiologyBiogeography and phylogeographyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|May 14, 2026

Apoptosis and Glial Marker Profiles in Hippocampus and Amygdala of Medically Intractable Temporal Lobe Epilepsy.

|Jul 29, 2025

Enhancing cardiorespiratory fitness and quality of life in high-grade glioma through an intensive exercise intervention during chemotherapy: Proof of concept.

Johanna Jost-Engl, Ralf Ketter, Ralf Brandt

|May 12, 2025

Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation.

Rainer Wiewrodt, Maren Kloss, Johanna Jost-Engl

|Apr 23, 2025

Synthetic O-(2-<sup>18</sup>F-fluoroethyl)-l-tyrosine-positron emission tomography generation and hotspot prediction via preoperative MRI fusion of gliomas lacking radiographic high-grade characteristics.

Eric Suero Molina, Mehnaz Tabassum, Ghasem Azemi

|Oct 01, 2024

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Thomas Zeyen, Laura Böhm, Daniel Paech

|Apr 02, 2024

Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.

Walter Stummer, Michael Müther, Dorothee Spille

Pageof 3

Frequent Collaborators

Dorothee Wiewrodt

Johanna Jost-Engl

Daniel A Orringer

Stephanie Schipmann

Peter Hau

Alice Ryba

Manfred Westphal

Ulrich Schüller

Malte Mohme

Fabian M Troschel

Frequent Collaborators

Dorothee Wiewrodt

Johanna Jost-Engl

Daniel A Orringer

Stephanie Schipmann